Entegris, Inc.

The stock remains in a long-term uptrend, trading well above its 200-day average of 113.66 and its 50-day average of 146.22. It is still below the 52-week high of 186.94, so the regime is constructive but not fully extended.

Street sentiment is positive, with a Buy consensus and an average target of 152.71, modestly below the last close. Recent target work has skewed higher, including moves to 205 at UBS and 180 at Mizuho, while one downgrade to Hold from Deutsche Bank keeps the range disciplined.

The company has beaten EPS in 4 of the last 7 quarters, including a 14.7% beat in the most recent reported quarter and a 6.1% beat before that. Next-quarter EPS is estimated at 0.81, so shareholders should watch whether the beat streak extends and whether margins hold.

Recent insider activity leans to net selling, with several discretionary sales clustered in May and early June. The main noise comes from award, exempt, and exercise-related entries, but the repeated sales by senior leaders and a director point to a cautious insider posture.

Profitability is solid but not elite, with gross margin at 44.8%, operating margin at 17.95%, and net margin at 8.18%. Growth is improving, with revenue up 5.0% year over year and earnings up 46.3%, while free cash flow reached $994.6 million on $695.4 million of operating cash flow.

ENTG sits in semiconductor materials and contamination-control niches where product depth and process criticality matter more than headline scale. The valuation is rich at 54.91 times earnings, so the setup favors execution over multiple expansion versus the group.